A randomized controlled trial on choosing a transvaginal tenchnique for ultrasound-indicated cerclage

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061699

Enrollment

Unknown

Registered

2022-06-30

Start date

2022-06-30

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preterm delivery

Interventions

McDonald cerclage:McDonald cerclage

Shirodkar cercalge:Shirodkar cercalge

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Singleton pregnant women with ultrasound-indicated cervical shortening before 27+6 gestational weeks, and willing to accept cervical cerclage.

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancy; 2. Pregnant women suspected to have chorioamnionitis, active labor and preterm premature rupture of membranes.

Design outcomes

Primary

Measure	Time frame
gestational week of delivery;Prolonged days of gestation;	—

Secondary

Measure	Time frame
serum biomarkers post-surgery;cervical length;gestational week at the time of cerclage;gravidity;parity;	—

Countries

China

Contacts

Public ContactQiong Luo

Women's Hospital, Zhejiang University School of Medicine

luoq@zju.edu.cn+86 13958023267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026